# Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children

> **NCT00178503** · PHASE2,PHASE3 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 24 (actual)

## Conditions studied

- Autism
- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Methylphenidate-extended release
- **DRUG:** Methylphenidate-immediate release
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00178503
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00178503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00178503, "Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00178503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*